PMID: 2312602Jan 1, 1990Paper

Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study

Journal of Cancer Research and Clinical Oncology
H ScherüblR Ziegler


A group of 20 patients with advanced medullary (MTC) or differentiated thyroid carcinoma (DTC) received a combination chemotherapy of doxorubicin (50 mg/m2), cisplatin (60 mg/m2) and vindesine (3 mg/m2). In the 18 (10 MTC, 8 DTC) evaluable patients only 1 partial remission (in a patient with MTC) and 3 minor responses (in 3 patients with DTC) were observed. These responses lasted for 15, 9, 13, and 22 months, respectively. Three MTC patients suffered from progressive disease and "no change" was seen in the other 11 patients. Toxicity, including 1 severe case of cardiomyopathy, was considerable. Thus, the combination chemotherapy of doxorubicin, cisplatin and vindesine has failed to prove superior to the commonly applied doxorubicin monotherapy in patients with advanced medullary or differentiated thyroid carcinoma.


Jul 1, 1988·The Australian and New Zealand Journal of Surgery·H K NgJ C Lee
Jun 1, 1987·Journal of Endocrinological Investigation·S Ahuja, H Ernst
Feb 1, 1985·The Journal of Clinical Endocrinology and Metabolism·N A SamaanN G Ordonez
Jan 24, 1974·The New England Journal of Medicine·J A Gottlieb, C S Hill
Jan 1, 1980·Journal of Surgical Oncology·K Shimaoka
Mar 18, 1983·Deutsche medizinische Wochenschrift·G Benker, D Reinwein
Oct 1, 1983·American Journal of Clinical Oncology·R M BukowskiJ Purvis
Jan 1, 1981·Cancer·A B MillerA Winkler

❮ Previous
Next ❯


Jan 16, 1999·Seminars in Surgical Oncology·B R Haugen
Oct 3, 2007·Investigational New Drugs·Athanassios ArgirisSally E Carty
Aug 29, 2003·Current Treatment Options in Oncology·Jeffrey F Moley
Jun 22, 2005·Current Treatment Options in Oncology·Amber Traugott, Jeffrey F Moley
Oct 1, 1991·Pharmacology & Therapeutics·E K Rowinsky, R C Donehower
Jul 29, 1998·Journal of Internal Medicine·J F MoleyS A Wells
Oct 1, 1995·Thyroid : Official Journal of the American Thyroid Association·D J MarshB G Robinson
Aug 17, 2006·Thyroid : Official Journal of the American Thyroid Association·Lisa K GilliamCheryl A Pickett
Nov 8, 2007·Thyroid : Official Journal of the American Thyroid Association·Nathan A PennellThomas J Lynch
May 28, 2009·Thyroid : Official Journal of the American Thyroid Association·UNKNOWN American Thyroid Association Guidelines Task ForceSamuel A Wells
Jan 1, 2010·Therapeutic Advances in Medical Oncology·Jennifer A Sipos, Manisha H Shah
Mar 19, 2008·Current Problems in Surgery·Elizabeth G GrubbsDouglas B Evans
Sep 25, 2007·Surgical Oncology·Pamela M Aubert, Richard J O'Donnell
Nov 29, 2015·Seminars in Oncology·Daniel C McFarlandKrzysztof Misiukiewicz
Mar 20, 2013·International Journal of Endocrinology·Serena GiuntiLibero Santarpia
Jul 16, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·F PaciniM Schlumberger
Apr 6, 2001·Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism·K B Ain
May 27, 2008·Endocrinology and Metabolism Clinics of North America·Jessica E Gosnell, Orlo H Clark
Dec 2, 2008·Otolaryngologic Clinics of North America·John Y Jun, Andrea Manni
Nov 30, 2006·Journal of Surgical Oncology·Elizabeth A Fialkowski, Jeffrey F Moley
Jun 20, 2014·Cancer·Jessica E MaxwellJames R Howe
Feb 3, 2007·Head & Neck·Aron PopovtzerRafael Feinmesser
Feb 19, 2005·Journal of Surgical Oncology·Frank J Quayle, Jeffrey F Moley
Feb 13, 2015·Clinical Nuclear Medicine·William MakisAlexander J B McEwan
Jan 1, 1997·Cancer Control : Journal of the Moffitt Cancer Center·M G Franz
Apr 12, 2016·Endocrine-related Cancer·Ana AlberoTomas Martín
May 9, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Jessica E GosnellQuan-Yang Duh
Oct 14, 2017·Clinical Case Reports·Nathamon PanomuppakarnNuttapong Ngamphaiboon
Jul 13, 2006·Archives of Pathology & Laboratory Medicine·Rosaria Maddalena RuggeriMaria Trovato

❮ Previous
Next ❯

Related Concepts

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.